article thumbnail

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Digital Health Global

Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.

article thumbnail

Pfizer, Tempus collaborate on cancer drug development

Mobi Health News

The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

LabCorp's latest deal hones in on digital clinical trials for drug development

Mobi Health News

The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.

article thumbnail

Demystifying AI: A Review of the Fundamentals and Applications in Drug Development

ActiGraph

The field of drug development is no exception. In this blog post, we'll explore the history of AI, clarify key concepts and common questions, and delve into its use in drug development.

article thumbnail

Sanofi and TrialSpark partner to accelerate tech-driven drug development

Mobi Health News

The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.

article thumbnail

AI drug developer Alto Neuroscience raises $25M and more digital health fundings

Mobi Health News

Cough monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.

article thumbnail

Debiopharm and ThinkingNodeLife.ai Forge a Strategic Partnership to Propel Cancer Drug Development with AI Digital Cell Clones

Digital Health Global

As we look forward to an exhilarating 2024, we believe this partnership will pave the way for significant advancements in the field of drug R&D for the benefit of the patients,” explained Khai Pham, CEO of ThinkingNodeLife.ai Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.